NKG2D-Based Chimeric Antigen Receptor Therapy Induced Remission In A Relapsed/Refractory Acute Myeloid Leukemia Patient.

NKG2D-Based Chimeric Antigen Receptor Therapy Induced Remission In A Relapsed/Refractory Acute Myeloid Leukemia Patient.

Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types

Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types

NKG2D-based CAR-T therapy in a Multinational Phase 1 Dose Escalation and Expansion Study Targeting Multiple Solid and Hematologic Tumor Types.

NKG2D-based CAR-T therapy in a Multinational Phase 1 Dose Escalation and Expansion Study Targeting Multiple Solid and Hematologic Tumor Types.

Celyad issues a White Paper about CAR T NKR-2 current knowledge and differences with classical CAR-T technologies

Celyad issues a White Paper about CAR T NKR-2 current knowledge and differences with classical CAR-T technologies

Wu et al. - 2015 - B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

Wu et al. - 2015 - B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

Sentman et Meehan - 2014 - NKG2D CARs as Cell Therapy for Cancer

Sentman et Meehan - 2014 - NKG2D CARs as Cell Therapy for Cancer

Spear et al. - 2013 - NKG2D CAR T cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors (only in english)

Spear et al. - 2013 - NKG2D CAR T cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors (only in english)

Spear et al. - 2013 - Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors (only in english)

Spear et al. - 2013 - Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors (only in english)

Zhang et Sentman - 2013 - Mouse Tumor Vasculature Expresses NKG2D Ligands and Can Be Targeted by Chimeric NKG2D-Modified T Cells (only in english)

Zhang et Sentman - 2013 - Mouse Tumor Vasculature Expresses NKG2D Ligands and Can Be Targeted by Chimeric NKG2D-Modified T Cells (only in english)

Zhang et al. - 2012 - An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo

Zhang et al. - 2012 - An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo

Spear et al. - 2012 - Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF (only in english)

Spear et al. - 2012 - Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF (only in english)

Barber et al. - 2011 - Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells

Barber et al. - 2011 - Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells